Day One Biopharmaceuticals Inc. (DAWN) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Day One Biopharmaceutical...

    NASDAQ: DAWN · Real-Time Price · USD
    7.95
    0.52 (7.00%)
    At close: Oct 03, 2025, 3:59 PM
    8.02
    0.88%
    After-hours: Oct 03, 2025, 05:42 PM EDT

    Day One Biopharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 124.97M 230.78M 85.26M 284.31M
    Short-Term Investments
    		 406.75M 135.56M 257.01M n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 121K 214K 469K 169K
    Receivables
    		 13.88M n/a n/a n/a
    Inventory
    		 3.32M n/a n/a n/a
    Other Current Assets
    		 4.37M 2.35M 1.01M 1.01M
    Total Current Assets
    		 562.33M 375.27M 347.87M 289.37M
    Property-Plant & Equipment
    		 4.71M 560K 719K 284K
    Goodwill & Intangibles
    		 15.63M n/a n/a n/a
    Total Long-Term Assets
    		 20.46M 774K 1.19M 453K
    Total Assets
    		 582.79M 376.05M 349.06M 289.82M
    Account Payables
    		 3.26M 2.58M 260K 1.74M
    Deferred Revenue
    		 1.55M n/a n/a 6.61M
    Short-Term Debt
    		 10K n/a 405K 204K
    Other Current Liabilities
    		 68.61M 1.04M 9.42M -100K
    Total Current Liabilities
    		 73.45M 29.51M 16.61M 8.66M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 761K n/a n/a n/a
    Total Long-Term Liabilities
    		 6.59M n/a 408K 16K
    Total Liabilities
    		 80.04M 29.51M 17.02M 8.67M
    Total Debt
    		 2.6M 408K 813K 220K
    Book Value
    		 502.75M 346.54M 332.04M 281.15M
    Book Value Per Share
    		 5.37 4.34 5.07 4.54
    Common Stock
    		 10K 9K 7K 6K
    Retained Earnings
    		 -554.08M -458.58M -269.67M -127.49M
    Comprehensive Income
    		 84K 9K -71K n/a
    Shareholders Equity
    		 502.75M 346.54M -269.67M -127.49M
    Total Investments
    		 406.75M 135.56M 257.01M n/a

    Add to Watchlist